Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 159 publications
Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma.
Journal: Journal for immunotherapy of cancer
Published: April 15, 2026
Biallelic NF1 Inactivation and Widespread Loss of Heterozygosity in a Subset of Unclassified Fibromyxoid Mesenchymal Neoplasms.
Journal: Genes, chromosomes & cancer
Published: December 23, 2025
Scalp cooling outcomes in patients receiving trastuzumab deruxtecan for metastatic breast cancer.
Journal: ESMO open
Published: November 23, 2025
Overall survival from the open-label phase II trial of palbociclib in patients with advanced well-differentiated/dedifferentiated liposarcoma.
Journal: ESMO open
Published: October 29, 2025
Histologic Subvariants of Retroperitoneal Well-Differentiated Liposarcoma Show Evidence of Clinical and Genomic Progression Toward Dedifferentiated Liposarcoma.
Journal: JCO precision oncology
Published: September 24, 2025
Novel genomic risk stratification model for primary high-grade malignant peripheral nerve sheath tumor (MPNST).
Journal: The Journal of pathology
Published: August 22, 2025
A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy.
Journal: Cell
Published: August 19, 2025
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: July 16, 2025
Can artificial intelligence deliver on the promise of precision medicine?
Journal: Hepatobiliary surgery and nutrition
Published: June 28, 2025
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma.
Journal: Cancer research communications
Published: June 25, 2025
Identifying subsets of patients with retroperitoneal sarcoma who benefit from radiotherapy: an Interpretable AI reanalysis of the STRASS randomised trial.
Journal: The Lancet. Digital health
Published: June 11, 2025
Exacerbation of paraneoplastic cerebellar degeneration by immune checkpoint inhibitor use in endometrial cancer.
Journal: Gynecologic oncology reports
Published: May 06, 2025
Last Updated: 09/26/2026